Aragen Life Sciences IPO Plans $160.5m Expansion

TL;DR: Aragen Life Sciences will invest Rs 15 billion over three years to expand its drug development and manufacturing capacity before its IPO. Aragen Life Sciences aims to spend Rs 15 billion over three years on drug development and manufacturing expansion ahead of its stock market debut. Aragen Life Sciences plans to spend Rs 15 billion over three years for expansion.

ReutersNov 18, 2026

From · · · 40s

TL;DR: Aragen Life Sciences IPO Plans $160.5m Expansion

Aragen Life Sciences aims to spend Rs 15 billion over three years on drug development and manufacturing expansion ahead of its stock market debut.

Aragen Life Sciences will invest Rs 15 billion over three years to expand its drug development and manufacturing capacity before its IPO. Aragen Life Sciences aims to spend Rs 15 billion over three years on drug development and manufacturing expansion ahead of its stock market debut. Aragen Life Sciences plans to spend Rs 15 billion over three years for expansion.

  • IPO-bound Aragen expansion plans
  • Investment breakdown
  • Capacity expansion targets

Read the story version — the same reporting as a swipeable deck of 3 cards.

Read the original on The Economic Times

How we make summaries

React

Sign in to react and comment.

Comments (0)

Life is short. Keep it sweet. Respect others' opinions and be kind!

    Recommended next

    More decks on aragen life sciences and related topics.